These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22062955)

  • 1. Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium.
    Hefer D; Yi T; Selby DE; Fishbaugher DE; Tremble SM; Begin KJ; Gogo P; Lewinter MM; Meyer M; Palmer BM; Vanburen P
    J Mol Cell Cardiol; 2012 Jan; 52(1):256-63. PubMed ID: 22062955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.
    Wright GL; Hanlon P; Amin K; Steenbergen C; Murphy E; Arcasoy MO
    FASEB J; 2004 Jun; 18(9):1031-3. PubMed ID: 15059965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium.
    von Lewinski D; Voss K; Hülsmann S; Kögler H; Pieske B
    Circ Res; 2003 Feb; 92(2):169-76. PubMed ID: 12574144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
    Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
    Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
    Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation.
    Hussain RI; Qvigstad E; Birkeland JA; Eikemo H; Glende A; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Krobert KA
    Br J Pharmacol; 2009 Feb; 156(4):575-86. PubMed ID: 19159405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling.
    Grimm M; Mahnecke N; Soja F; El-Armouche A; Haas P; Treede H; Reichenspurner H; Eschenhagen T
    Br J Pharmacol; 2006 Aug; 148(7):991-1000. PubMed ID: 16783412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
    Shahid M; Martorana MG; Cottney JE; Marshall RJ
    Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a PKCepsilon-dependent regulation of myocardial contraction by epicatechin-3-gallate.
    Li D; Yang C; Chen Y; Tian J; Liu L; Dai Q; Wan X; Xie Z
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H345-53. PubMed ID: 17951366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin protects against doxorubicin-induced heart failure.
    Ammar HI; Saba S; Ammar RI; Elsayed LA; Ghaly WB; Dhingra S
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2413-21. PubMed ID: 21984540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
    Ahmet I; Tae HJ; Juhaszova M; Riordon DR; Boheler KR; Sollott SJ; Brines M; Cerami A; Lakatta EG; Talan MI
    Mol Med; 2011; 17(3-4):194-200. PubMed ID: 21170473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropic actions of protein kinase C activation by phorbol dibutyrate in guinea-pig isolated ventricular myocytes.
    Mamas MA; Terrar DA
    Exp Physiol; 2001 Sep; 86(5):561-70. PubMed ID: 11571483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
    J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction and Ca2+ signaling in contractile regulation induced by crosstalk between endothelin-1 and norepinephrine in dog ventricular myocardium.
    Chu L; Takahashi R; Norota I; Miyamoto T; Takeishi Y; Ishii K; Kubota I; Endoh M
    Circ Res; 2003 May; 92(9):1024-32. PubMed ID: 12690035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.
    Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H
    Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of cardioprotection by erythropoietin.
    Burger D; Xenocostas A; Feng QP
    Curr Mol Pharmacol; 2009 Jan; 2(1):56-69. PubMed ID: 20021446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.